I still don’t understand why Bamlanivimab(Eli) was able to change their primary endpoint during interim analysis and receive an EUA for reducing hospitalization by 7% of a small sample size. When the safety monitoring board checked our data, they suggested we wait until day 48 before calculating how we stacked up against placebo, even though, we were dominating placebo at Day 10 since our 2nd and last shot was given on Day 7. I always wonder why they would encourage us to wait 20 days longer than set date when these professionals could obviously see our treatment fading as the weeks passed without more Leronlimab injections occurring(very shady). IMHO, if leronlimab was produced by any Big Pharm company, it would be approved and would be saving lives around the world since at least mid 2020. And we would be rolling in dough so high, Scrooge McDuck would be jealous. At least we have Brazil, because I have no respect for the FDA at this time. Let’s start jabbing and show what a disgrace the FDA is for slow playing us and recklessly endangering thousands of Americans. SAD STUFF!!!!